Anoro Ellipta FDA Approved Drugs
ANORO ELLIPTA [Umeclidinium BromideC29H34NO2Br : Vilanterol TrifenatateC24H33Cl2NO5C20H16O2]
eq 0.0625mg base/inh : eq 0.025mg base/inh (inhalation powder)
GlaxosmithklineDec 18, 2013
- Indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema..
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.